Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ning Hongmei
Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Donor-Cell Leukemia With Novel Genetic Features 2 Years After Sex-Mismatched T Cell-Depleted Haploidentical Stem Cell Transplantation
Annals of Hematology
Medicine
Hematology
Clinical Outcome of Allogeneic SCT With a RIC Regimen in Young Adults With AML in CR1; Impact of Prior Consolidation Therapy
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
ERRATUM: Haploidentical Related Donor Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency Using Post-Transplantation Cyclophosphamide
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Tacrolimus Compared With Cyclosporine a After Haploidentical T-Cell Replete Transplantation With Post-Infusion Cyclophosphamide
Bone Marrow Transplantation
Transplantation
Hematology
Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Haploidentical/Mismatched Hematopoietic Stem Cell Transplantation Without in Vitro T Cell Depletion for T Cell Acute Lymphoblastic Leukemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Comments on the Article ‘Donor-Derived CD19-targeted T Cell Infusion Induces Minimal Residual Disease-Negative Remission in Relapsed B-Cell Acute Lymphoblastic Leukaemia With No Response to Donor Lymphocyte Infusions After Haploidentical Haematopoietic St
British Journal of Haematology
Hematology
Severity of Cytokine Release Syndrome as a Predictor of Infections After T-Cell Replete Haploidentical Hematopoietic Cell Transplantation (haploHCT)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
Frontiers in Oncology
Cancer Research
Oncology
